Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

Insulet Corporation PODD reported first-quarter adjusted earnings of $1.02 per share, beating the consensus of 80 cents.The automated insulin delivery technology maker reported sales of $569 million, up 28.8% year over year (29.8% in constant currency), beating the consensus of $543.4 million, exceeding the high end of the company’s guidance range of 25% in constant currency.Total Omnipod revenue reached $554.1 million, an increase of 28.0%, or 29.0% in constant currency.U.S. Omnipod revenue of $401.7 milli ...